Get the Stockscreener App
6.80
4.09%
-0.29
After Hours:
6.78
-0.02
-0.29%
Gyre Therapeutics Inc Stock (GYRE) Forecast
The Gyre Therapeutics Inc (GYRE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.2249, representing a -37.87% decrease from the current price of $6.80. The highest analyst price target is $3.2349, and the lowest is $5.2149.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GYRE Price Target
Average 16.89
(+148.40% Upside)
Is Gyre Therapeutics Inc (GYRE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.16 | Neutral |
| STOCH(9,6) | 16.88 | Buy |
| STOCHRSI(14) | 14.12 | Buy |
| MACD(12,26) | -1.093 | Sell |
| ADX(14) | 26.04 | Sell |
| William %R | -89.92 | Buy |
| CCI(14) | -94.73 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.342
Sell
|
8.1666
Sell
|
| MA20 |
9.6255
Sell
|
9.1461
Sell
|
| MA50 |
10.83
Sell
|
10.31
Sell
|
| MA100 |
11.26
Sell
|
11.12
Sell
|
| MA200 |
12.09
Sell
|
12.32
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GYRE could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on GYRE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.16 indicates that GYRE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.88 indicates that GYRE is oversold. This indicates that GYRE price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.12 indicates that GYRE is oversold. This suggests that GYRE price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.04 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -94.73 indicates that GYRE is still oversold but not to an extreme extent.
Long-term GYRE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Gyre Therapeutics Inc financial reports and earnings history, Gyre Therapeutics Inc (GYRE) stock could reach $120.05 by 2030, $366.93 by 2040 and $413.14 by 2050. See the projected annual prices until 2050 of the Gyre Therapeutics Inc stock below:
- Gyre Therapeutics Inc (GYRE) is expected to reach an average price of $174.51 in 2035, with a high prediction of $192.04 and a low estimate of $175.84. This indicates an $2,466% rise from the last recorded price of $6.80.
- Gyre Therapeutics Inc (GYRE) stock is projected to chart a bullish course in 2040, with an average price target of $362.92, representing an $5,237% surge from its current level. The forecast ranges from a conservative $218.37 to a sky-high $366.93.
- Our analysts predict Gyre Therapeutics Inc (GYRE) to jump 5,629% by 2045, soaring from $393.66 to an average price of $389.58, potentially reaching $421.96. While $393.66 is the low estimate, the potential upside is significant.
- Gyre Therapeutics Inc (GYRE) stock is expected to climb by 2050, reaching an average of $377.33, a $5,449% jump from its current level. However, a wide range of estimates exists, with high and low targets of $413.14 and $377.50, respectively, highlighting the market's uncertainty.
Gyre Therapeutics Inc Stock (GYRE) Year by Year Forecast
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2025
Gyre Therapeutics Inc Stock (GYRE) is expected to reach an average price of $11.50 in 2025, with a high prediction of $22.88 and a low estimate of $0.1204. This indicates an +69.12% rise from the last recorded price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $4.3249 | $5.2149 | $3.2349 | -36.40% |
| June, 2025 | $4.0741 | $4.9941 | $3.2595 | -40.09% |
| July, 2025 | $16.03 | $2.9887 | $13.05 | +135.78% |
| August, 2025 | $23.94 | $19.28 | $21.94 | +251.99% |
| September, 2025 | $14.19 | $14.19 | $20.41 | +108.64% |
| October, 2025 | $10.96 | $12.29 | $10.62 | +61.22% |
| November, 2025 | $8.2252 | $9.9902 | $10.18 | +20.96% |
| December, 2025 | $28.51 | $9.1283 | $22.88 | +319.30% |
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2026
The predicted value for Gyre Therapeutics Inc (GYRE) in 2026 is set at an average of $31.89. Estimates vary from a peak of $48.51 to a trough of $15.27, indicating an +368.97% surge from the present price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.36 | $32.51 | $30.79 | +361.22% |
| February, 2026 | $18.86 | $22.27 | $23.85 | +177.33% |
| March, 2026 | $18.07 | $19.40 | $17.84 | +165.79% |
| April, 2026 | $15.10 | $15.27 | $17.09 | +122.03% |
| May, 2026 | $37.95 | $16.23 | $32.71 | +458.15% |
| June, 2026 | $40.03 | $41.18 | $39.65 | +488.64% |
| July, 2026 | $28.92 | $29.58 | $32.32 | +325.30% |
| August, 2026 | $24.55 | $25.93 | $25.15 | +261.02% |
| September, 2026 | $22.33 | $21.41 | $23.24 | +228.32% |
| October, 2026 | $49.80 | $45.64 | $44.04 | +632.37% |
| November, 2026 | $43.91 | $48.88 | $48.51 | +545.77% |
| December, 2026 | $35.73 | $36.58 | $34.28 | +425.51% |
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Gyre Therapeutics Inc (GYRE) is $49.79, with a high forecast of $72.03 and a low forecast of $27.55. This indicates an +632.18% increase from the last price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.25 | $32.85 | $32.45 | +344.79% |
| February, 2027 | $28.23 | $27.55 | $28.91 | +315.10% |
| March, 2027 | $60.05 | $55.28 | $56.67 | +783.16% |
| April, 2027 | $44.18 | $52.66 | $57.37 | +549.69% |
| May, 2027 | $43.23 | $44.08 | $42.17 | +535.79% |
| June, 2027 | $36.71 | $37.63 | $39.76 | +439.92% |
| July, 2027 | $64.78 | $33.69 | $62.20 | +852.65% |
| August, 2027 | $69.11 | $64.91 | $65.73 | +916.29% |
| September, 2027 | $54.60 | $54.60 | $66.23 | +702.90% |
| October, 2027 | $48.15 | $49.04 | $50.06 | +608.16% |
| November, 2027 | $43.24 | $44.16 | $45.67 | +535.92% |
| December, 2027 | $73.85 | $39.83 | $72.03 | +986.00% |
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2028
In 2028, Gyre Therapeutics Inc (GYRE) is projected to reach an average price of $69.42, with a high projection of $92.89 and a low estimate of $45.95. This indicates an +920.88% rise from the last price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $77.09 | $75.92 | $75.09 | +1,034% |
| February, 2028 | $62.68 | $62.68 | $72.40 | +821.75% |
| March, 2028 | $53.63 | $54.96 | $57.95 | +688.64% |
| April, 2028 | $46.23 | $47.99 | $51.68 | +579.82% |
| May, 2028 | $85.16 | $45.95 | $81.86 | +1,152% |
| June, 2028 | $83.35 | $84.50 | $83.95 | +1,126% |
| July, 2028 | $66.18 | $70.26 | $74.67 | +873.30% |
| August, 2028 | $59.13 | $60.52 | $62.63 | +769.58% |
| September, 2028 | $51.94 | $52.11 | $56.86 | +663.75% |
| October, 2028 | $94.60 | $51.90 | $91.69 | +1,291% |
| November, 2028 | $86.26 | $91.23 | $92.89 | +1,169% |
| December, 2028 | $75.08 | $75.74 | $75.24 | +1,004% |
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2029
The 2029 price forecast for Gyre Therapeutics Inc Stock (GYRE) is $89.51 on average, with a high prediction of $121.18 and a low estimate of $57.84. This represents an +1,216% increase from the previous price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $63.86 | $67.34 | $70.03 | +839.08% |
| February, 2029 | $59.70 | $57.84 | $61.55 | +777.87% |
| March, 2029 | $105.28 | $103.45 | $101.52 | +1,448% |
| April, 2029 | $94.73 | $99.70 | $101.94 | +1,293% |
| May, 2029 | $80.73 | $81.58 | $83.52 | +1,087% |
| June, 2029 | $70.58 | $74.07 | $76.28 | +937.93% |
| July, 2029 | $65.93 | $63.79 | $68.07 | +869.59% |
| August, 2029 | $114.37 | $113.09 | $111.35 | +1,582% |
| September, 2029 | $93.84 | $102.32 | $110.52 | +1,280% |
| October, 2029 | $84.68 | $85.57 | $89.50 | +1,145% |
| November, 2029 | $75.88 | $76.80 | $81.22 | +1,016% |
| December, 2029 | $123.76 | $69.73 | $121.18 | +1,720% |
Gyre Therapeutics Inc Stock (GYRE) Price Forecast for 2030
Gyre Therapeutics Inc Stock (GYRE) is expected to reach an average price of $108.26 in 2030, with a high forecast of $140.84 and a low forecast of $75.68. This signifies an +1,492% surge from the last price of $6.80.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $121.38 | $121.95 | $120.05 | +1,685% |
| February, 2030 | $103.09 | $103.09 | $115.72 | +1,416% |
| March, 2030 | $91.98 | $92.87 | $97.39 | +1,253% |
| April, 2030 | $82.41 | $83.33 | $88.33 | +1,112% |
| May, 2030 | $131.66 | $75.68 | $131.01 | +1,836% |
| June, 2030 | $130.24 | $130.81 | $129.10 | +1,815% |
| July, 2030 | $105.62 | $109.70 | $124.38 | +1,453% |
| August, 2030 | $96.29 | $97.62 | $101.10 | +1,316% |
| September, 2030 | $84.23 | $86.00 | $93.17 | +1,139% |
| October, 2030 | $141.81 | $81.63 | $140.84 | +1,985% |
| November, 2030 | $135.34 | $136.49 | $138.15 | +1,890% |
| December, 2030 | $113.51 | $117.59 | $125.50 | +1,569% |
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):